Plymouth, Mich., USA - January 7, 2013, Plymouth, Mich., USA - Esperion Therapeutics, a developer of small-molecule therapies for the treatment of cardiometabolic disorders, announced that Timothy M. Mayleben has been named president and CEO of the company.
Article continues below
Most recently, Mr. Mayleben was president and chief executive officer at Aastrom Biosciences. He served as an advisor to life science and healthcare companies through his advisory and investment firm, ElMa Advisors since 2004. Previously, he served as the President and CEO and a Director of NightHawk Radiology Holdings, and he was the COO of the original Esperion Therapeutics, which later became a division of Pfizer Global Research & Development.
Mr. Mayleben is on the Advisory Board for the Wolverine Venture Fund and serves as a director for several private life science companies. He holds a MBA degree, with distinction, from the J.L. Kellogg Graduate School of Management at Northwestern University, and a BBA degree from the University of Michigan Ross School of Business.
The company also announced that Roger Newton, Ph.D., FAHA, who is the founder of Esperion and has been serving as its president and CEO, will become executive chairman and chief scientific officer.
Mr. Newton, Ph.D. has worked for 30 in the pharmaceutical and life sciences industries. He is Founder, Executive Chairman and Chief Scientific Officer of Esperion Therapeutics. Prior to that, he was Senior Vice President, Pfizer Global R&D, and Director, Esperion Therapeutics, a Pfizer company. He was a Co-founder, President & CEO of the original Esperion founded in July 1998.
Mr. Newton is an Adjunct Associate Professor in the Department of Pharmacology at the University of Michigan Medical School. He has co-authored nearly one hundred peer-reviewed articles and chapters during his research career. He has a Ph.D. in nutrition from the University of California, Davis, a MS degree in nutritional biochemistry from the University of Connecticut, and a BSc degree in biology from Lafayette College. ■